November 11, 2019   DIABETIC EYE DISEASE AWARENESS Risk factors and recommendations for DR, DME The statistics for patients’ awareness of the risk factors and recommendations for diabetic retinopathy and diabetic macular edema are alarming. Here is a closer look for clinicians. Learn more ADVERTISEMENT   Central subfield thickness only partially responsible for changes in acuity A post-hoc analysis of Protocol T from the DRCR Retina Network—which compared anti-VEGF compounds aflibercept, bevacizumab, and ranibizumab—has found changes in central subfield thickness account for only a small proportion of the total variation in visual acuity changes in DME patients. As such, changes in OCT should not be used as a guide to inform the physician or patient about changes in visual acuity after anti-VEGF treatment. Find out